Ultragenyx Pharmaceutical (UP0.STU) Q2 2026 Earnings

5MayConfirmed
Q1 2026
Q2 2026
-1.57
-1.35
-1.14
-0.92

Details

Expected EPS
-1.2696787623399999
Actual EPS
-1.5702376
Surprise EPS
-0.3
Surprise Percent
+23.67%

Description

Ultragenyx Pharmaceutical (UP0.STU) has reported earnings of -1.5702376 per share for Q2 2026.

0 Comments

Share your thoughts